» Articles » PMID: 18804145

Increased Vulnerability to Rotenone-induced Neurotoxicity in Ceruloplasmin-deficient Mice

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2008 Sep 23
PMID 18804145
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Ceruloplasmin (Cp) is the strongest ferroxidase in human plasma. Hereditary deficiency of this protein, named aceruloplasminemia, is an interesting model to elucidate the pathogenesis and pathophysiology of neurodegeneration induced by oxidative stress. Enhanced oxidative stress due to excessive iron accumulation is observed in the brains of aceruloplasminemia patients. Rotenone, a selective mitochondrial complex I inhibitor, induces neurodegeneration mimicking Parkinson's disease. We investigated the influence of Cp deficiency upon neurodegeneration using rotenone-treated, Cp-deficient mouse brains. Immunohistochemical examination showed that acrolein, one of the products of lipid peroxides, and ubiquitin were more markedly immunoreacted in the brains of rotenone-treated, Cp-deficient mice than in rotenone-untreated, Cp-deficient or rotenone-treated, wild-type mice. These molecules were localized in neuronal cells. These results suggested that rotenone-induced lipid peroxidation and accumulation of ubiquitin immunoreactivity were enhanced in the absence of Cp. Therefore, Cp may protect neuronal cells from oxidative stress-induced neurodegeneration.

Citing Articles

Untargeted metabolomics reveal pathways associated with neuroprotective effect of oxyresveratrol in SH-SY5Y cells.

Mahamud N, Songvut P, Muangnoi C, Rodsiri R, Dahlan W, Tansawat R Sci Rep. 2023; 13(1):20385.

PMID: 37989867 PMC: 10663518. DOI: 10.1038/s41598-023-47558-y.


Ceruloplasmin Deficiency Impaired Brain Iron Metabolism and Behavior in Mice.

Niu L, Zhou Y, Lu L, Su A, Guo X Cell Biochem Biophys. 2022; 80(2):385-393.

PMID: 35147903 DOI: 10.1007/s12013-022-01061-9.


Brain Ceruloplasmin Expression After Experimental Intracerebral Hemorrhage and Protection Against Iron-Induced Brain Injury.

Liu H, Hua Y, Keep R, Xi G Transl Stroke Res. 2018; 10(1):112-119.

PMID: 30315404 PMC: 6438204. DOI: 10.1007/s12975-018-0669-0.


Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.

Zanardi A, Conti A, Cremonesi M, DAdamo P, Gilberti E, Apostoli P EMBO Mol Med. 2017; 10(1):91-106.

PMID: 29183916 PMC: 5760856. DOI: 10.15252/emmm.201708361.


New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases.

Xu H, Jiang H, Xie J Front Mol Neurosci. 2017; 10:71.

PMID: 28360837 PMC: 5352910. DOI: 10.3389/fnmol.2017.00071.